Therapeutic vaccination refocuses t-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)
<p><strong>Background:</strong> Strong and broad antiviral T-cell responses targeting vulnerable sites of HIV-1 will likely be a critical component for any effective cure strategy.</p> <p><strong>Methods:</strong> BCN01 trial was a phase I, open-label, non-r...
Prif Awduron: | Mothe, B, Manzardo, C, Sanchez-Bernabeu, A, Coll, P, Morón-López, S, Puertas, MC, Rosas-Umbert, M, Cobarsi, P, Escrig, R, Perez-Alvarez, N, Ruiz, I, Rovira, C, Meulbroek, M, Crook, A, Borthwick, N, Wee, EG, Yang, H, Miró, JM, Dorrell, L, Clotet, B, Martinez-Picado, J, Brander, C, Hanke, T, BCN 01 study group |
---|---|
Fformat: | Journal article |
Cyhoeddwyd: |
Elsevier
2019
|
Eitemau Tebyg
-
In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&kill clinical trial
gan: Rosás-Umbert, M, et al.
Cyhoeddwyd: (2020) -
HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02)
gan: Mothe, B, et al.
Cyhoeddwyd: (2020) -
EyeAR: Refocusable augmented reality content through eye measurements
gan: Rompapas, D, et al.
Cyhoeddwyd: (2017) -
Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers
gan: Rosás-Umbert, M, et al.
Cyhoeddwyd: (2018) -
Digitally refocusing an unfocused image
gan: Yang, RuiZhi
Cyhoeddwyd: (2024)